Brief report
Interpersonal problems as predictors of alliance, symptomatic improvement and premature termination in treatment of depression

https://doi.org/10.1016/j.jad.2013.07.003Get rights and content

Abstract

Background

Previous studies reported inconsistent findings regarding the association of interpersonal problems with therapy outcome. The current study investigates if interpersonal problems predict process and outcome of three different treatments for depression.

Methods

The data originate from a randomized clinical trial comparing supportive–expressive psychotherapy, antidepressant medication and pill-placebo for treatment of depression. Interpersonal problems were used as predictors of alliance, symptomatic improvement and premature termination of treatment.

Results

Interpersonal problems related to communion predicted better alliances, but slower symptomatic improvement. Low agency predicted slower symptomatic improvement in supportive–expressive psychotherapy, but not in the medication or placebo condition. Lower interpersonal distress was associated with an increased likelihood to terminate treatment prematurely.

Limitations

The sample size did not allow the detection of small effects within the treatment groups.

Conclusions

Interpersonal problems are influential for the treatment of depression, but parts of their effects depend on the type of treatment.

Section snippets

Background

Interpersonal problems are common in depression. Not only do depressed patients report high interpersonal distress, they also describe specific problems related to low assertiveness such as social avoidance, submissiveness and exploitation (Barrett and Barber, 2007). But how do these issues relate to the process and outcome of treatment for depression?

Previous research examining the influence of interpersonal distress on outcome has failed to provide definitive answers. For example, Renner et

Participants and procedure

Details about inclusion criteria and study procedures are reported by Barber et al. (2012). The current sample consisted of 151 patients, mean age was 37.5 years (SD=12.12), 60.9% were female. Ethnicities included Caucasian (49%), African American (44%), Latino (5%) and Asian (2%). All patients met DSM-IV criteria for Major Depressive Disorder, and 85% had at least one comorbid disorder. Interpersonal problems, depressive symptoms and therapeutic alliance were assessed at intake by independent

Correlations at intake

At intake, the level of interpersonal distress did not correlate significantly with depression severity (r=0.15; p=0.062), but was associated with lower alliance expectations (r=−0.21, p=0.015). Although communion correlated with alliance expectations (r=0.30, p=0.001), agency was not related to either alliance or initial symptom severity (r′s between −0.01 and .05).

Interpersonal problems as predictors of alliance throughout treatment

Interpersonal distress as well as communion predicted alliance intercepts (see Table 1). Alliance scores showed a significant

Discussion

This study examined the influence of interpersonal problems on treatment alliance, outcome and premature termination in three treatments for depression. Overall, high levels of interpersonal distress predicted lower expectations for alliance at intake. Several previous studies found that patients with high interpersonal disturbances have difficulties in forming positive therapeutic alliances (e.g., Constantino and Smith-Hansen, 2008). However, previous studies were less consistent regarding the

Conclusions

The current study demonstrates that interpersonal problems predict therapeutic alliance, treatment outcome, and premature termination in treatments for depression, with findings partially dependent on treatment type. As depressive patients frequently experience interpersonal problems related to submissiveness, the role of low agency in psychotherapy should be investigated in future studies.

Role of funding source

The original study was conducted with support from NIMH grant R01 MH 061410 to J. P. Barber (P.I.). The sertraline and pill placebos were provided by a grant from Pfizer Corp. The current study was written with support from the German Research Foundation, grant number: DI 1690/2 to U. Dinger.

Conflict of interest

Dr. Dinger has received funding from the German Research Foundation (DFG). Dr. Barber has received funding from the National Institute of Mental Health (NIMH), and the National Institute on Drug Abuse (NIDA); authors' fees from Guilford Press, Basic Books, and Cambridge University Press; and honoraria from Lundbeck. The other authors declare no conflict of interest.

Acknowledgments

We are grateful to the research team at the University of Pennsylvania and to those colleagues who were involved in and supported the primary trial.

References (21)

  • F. Renner et al.

    Interpersonal problems as predictors of therapeutic alliance and symptom improvement in cognitive therapy for depression

    Journal of Affective Disorders

    (2012)
  • J.P. Barber et al.

    Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial

    Journal of Clinical Psychiatry

    (2012)
  • M.S. Barrett et al.

    Interpersonal profiles in major depressive disorder

    Journal of Clinical Psychology

    (2007)
  • M. Constantino et al.

    Patient interpersonal factors and the therapeutic alliance in two treatments for bulimia nervosa

    Psychotherapy Research

    (2008)
  • P. Crits-Christoph et al.

    Interpersonal problems and the outcome of Interpersonally oriented psychodynamic treatment of GAD

    Psychotherapy

    (2005)
  • P. Cuijpers et al.

    Comparing psychotherapy and pharmacotherapy for adult depression: adjusting for differential dropout rates

    Journal of Clinical Psychiatry

    (2010)
  • U. Dinger et al.

    Influences of patients' and therapists' interpersonal problems and therapeutic alliance on outcome in psychotherapy

    Psychotherapy Research

    (2007)
  • J. Fawcett et al.

    Clinical management–imipramine/placebo administration manual. NIMH Treatment of depression collaborative research program

    Psychopharmacology Bulletin

    (1987)
  • L. Gaston et al.

    The California psychotherapy alliance scales

  • M. Hamilton

    A rating scale for depression

    Journal of Neurology, Neurosurgery and Psychiatry

    (1960)
There are more references available in the full text version of this article.

Cited by (0)

View full text